Grown Rogue International (OTCMKTS:GRUSF – Get Free Report) and Arcadia Biosciences (NASDAQ:RKDA – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, earnings, dividends, risk, valuation, institutional ownership and analyst recommendations.
Profitability
This table compares Grown Rogue International and Arcadia Biosciences’ net margins, return on equity and return on assets.
Net Margins | Return on Equity | Return on Assets | |
Grown Rogue International | N/A | N/A | N/A |
Arcadia Biosciences | -129.74% | -84.27% | -55.17% |
Earnings and Valuation
This table compares Grown Rogue International and Arcadia Biosciences’ gross revenue, earnings per share and valuation.
Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
Grown Rogue International | $23.35 million | 5.35 | -$130,000.00 | $0.01 | 60.00 |
Arcadia Biosciences | $5.33 million | 0.68 | -$13.98 million | ($5.16) | -0.52 |
Institutional and Insider Ownership
9.3% of Grown Rogue International shares are owned by institutional investors. Comparatively, 17.7% of Arcadia Biosciences shares are owned by institutional investors. 23.2% of Grown Rogue International shares are owned by insiders. Comparatively, 1.8% of Arcadia Biosciences shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Analyst Recommendations
This is a breakdown of current ratings and price targets for Grown Rogue International and Arcadia Biosciences, as provided by MarketBeat.com.
Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
Grown Rogue International | 0 | 0 | 0 | 0 | N/A |
Arcadia Biosciences | 0 | 0 | 1 | 1 | 3.50 |
Arcadia Biosciences has a consensus price target of $6.00, indicating a potential upside of 123.88%. Given Arcadia Biosciences’ higher probable upside, analysts clearly believe Arcadia Biosciences is more favorable than Grown Rogue International.
Summary
Grown Rogue International beats Arcadia Biosciences on 9 of the 13 factors compared between the two stocks.
About Grown Rogue International
Grown Rogue International Inc., together with its subsidiaries, produces and sells cannabis products in the United States. It offers a range of cultivars for consumers, such as indicas, sativas, and hybrids; strain-specific prepackaged flowers; and pre-roll pack products, as well as provides consulting services. The company sells its products through direct-to-retail delivery and third-party delivery, wholesalers, and processors. Grown Rogue International Inc. is headquartered in Medford, Oregon.
About Arcadia Biosciences
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.
Receive News & Ratings for Grown Rogue International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grown Rogue International and related companies with MarketBeat.com's FREE daily email newsletter.